W. Scott Boyes
Chairman, Chief Executive Officer and President
W. Scott Boyes is the Chairman, President and Chief Executive Officer of MPX International. His responsibilities include leadership of MPX International, including, but not limited to, the general management, strategy and expansion of MPX International.
Mr. Boyes is a seasoned senior executive with diversified and cross-functional experience, combining MBA credentials with a strong career background in revenue development and general management. Prior to the acquisition of CGX Life Sciences Inc. by MPX, Mr. Boyes was President of CGX Life Sciences Inc. where he focused on general management. Since August 2008,
Mr. Boyes has been President of NCD Associates, where he focused his consulting services on financial restructuring, and revenue enhancement and streamlining business processes for distressed or high growth companies. In 2005, Mr. Boyes founded and developed Railcrew Xpress Corporation, a specialized passenger transportation company servicing U.S. railroads, and served as its President until 2008. There, he developed and led the sales and customer service teams, managed the acquisition and integration of three competitor companies and developed and deployed sophisticated dispatch, tracking and reporting technology. From 2000 to 2005, Mr. Boyes served as President and Chief Executive Officer of Hallcon Corporation where he was responsible for the senior executive management of the company and its operating subsidiaries. Previously, he served as a Vice President of a large Canadian Bank and Vice President and General Manager of a business unit within a multinational commercial finance company with a focus on marketing and revenue development.
Jeremy S. Budd
Executive VP, General Counsel, Corporate Secretary, and Director
Jeremy S. Budd is the Executive Vice President, General Counsel and Corporate Secretary of MPX International. His responsibilities will include all legal and regulatory matters, including general corporate , mergers and acquisitions as well as equity and debt financings. Mr. Budd has been practicing corporate and securities law, in Toronto, Ontario, since 2007 representing issuers and underwriters in a wide variety of capital market transactions. Mr. Budd obtained his J.D./M.B.A. from Osgoode Hall Law School and the Schulich School of Business at York University in 2005 and holds a Bachelor of Arts in philosophy from Huron University College at the University of Western Ontario.
Vice President, Finance + Accounting, Interim Chief Financial Officer
Jonathan Chu has a strong track record in financial management having held various senior financial accounting positions. Jonathan holds a CPA, CA and a B.Comm from McGill University.
Vice President, Cultivation
Dr. Cheema is an award winning and highly motivated professional with a Ph.D. in Plant Physiology and Biochemistry from the University of Guelph, an International Advanced Diploma in Computer Science and Human Resource Management and over 25 years of multidimensional experience and leadership background in new business development in the cannabis industry and a variety of other plant productions. Dr. Cheema’s experience includes being Head Grower at The Green Organic Dutchman and Director of Cultivation at Goldleaf Pharm/FIRG Inc., a subsidiary of Pyxus International. He brings diverse experience as a cannabis cultivation specialist, hydroponics culture specialist, project management leader, team builder, researcher/teacher and scientist. He has developed a unique “2-step direct flowering cultivation method coupled with other scientific techniques” which provides a methodology to increase the yield of cannabis 100% compared to the industry average high, while maintaining high cannabinoid content.
Chief Operating Officer, Canada
Michael Arnkvarn has an extensive management background in the operation of small to medium businesses since his graduation from McGill University in 1977 with a BSc in Agricultural Sciences.
Director of European Development
Daniel Fryer joined MPXI in 2018 and oversees market expansion and brand development across Europe. Previously, he founded Cannatlantic, a London-based advisory firm focusing on the global cannabis industry, where he worked with companies and investors as well as policy-makers and NGOs. Daniel began his cannabis career in the United States with leading extracts company, Moxie, and helped build the brand's footprint through license acquisition and joint ventures. Daniel was previously an analyst at J.P.Morgan in Los Angeles, and CrossCreek, a media financing and production company. He holds a B.S in Business Administration and Finance from the Marshall School of Business at the University of Southern California.
Director of Extraction and Processing
With a degree in Science and several years of extraction experience in multiple U.S. states, Mr. Varone has worked with multiple state-licensed facilities from start-ups to large-scale producers. He brings to MPXI expertise with both hydrocarbon and solventless extraction, lab design, SOP preparation and facility management. Mr. Varone will be working closely with MPXI’s management teams in Canada, Switzerland, Malta, Australia and South Africa as they continue to build-out and operate the Company’s extraction and processing functions in each of these countries.